| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 83.530 | 92.060 | 192.829 | - | - | - | - | - | - | - |
| Total Income - EUR | 83.530 | 92.061 | 192.831 | - | - | - | - | - | - | - |
| Total Expenses - EUR | 72.496 | 75.725 | 128.299 | - | - | - | - | - | - | - |
| Gross Profit/Loss - EUR | 11.034 | 16.336 | 64.532 | - | - | - | - | - | - | - |
| Net Profit/Loss - EUR | 9.269 | 15.415 | 62.175 | - | - | - | - | - | - | - |
| Employees | 10 | 12 | 18 | - | - | - | - | - | - | - |
Check the financial reports for the company - Anubita Medical Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 2.148 | 954 | 808 | - | - | - | - | - | - | - |
| Current Assets | 58.003 | 26.392 | 99.332 | - | - | - | - | - | - | - |
| Inventories | 18 | 544 | 18 | - | - | - | - | - | - | - |
| Receivables | 12.188 | 0 | 0 | - | - | - | - | - | - | - |
| Cash | 45.797 | 25.848 | 99.315 | - | - | - | - | - | - | - |
| Shareholders Funds | 46.252 | 15.460 | 77.373 | - | - | - | - | - | - | - |
| Social Capital | 45 | 45 | 44 | - | - | - | - | - | - | - |
| Debts | 13.899 | 11.886 | 22.767 | - | - | - | - | - | - | - |
| Income in Advance | 0 | 0 | 0 | - | - | - | - | - | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Anubita Medical Srl